Literature DB >> 6819850

Evaluation of an immunological test for occult bleeding from colorectal neoplasia.

J A Williams, R Hunter, M Smith, M E Coles, T W Hubert, D W Thomas.   

Abstract

A study to determine the reliability of a recently described test, the faecal human haemoglobin test (FHH), specific for human blood, in the detection of colorectal neoplasia, is reported. All of nineteen patients with proven cancers studied were shown to have detectable blood in the stools. Three of five patients with polyps in this series also had detectable blood in the stools by this test. Although three of nineteen control subjects had positive tests, two of these were subsequently found to have bleeding sites, and the third was normal on follow up some weeks later. The findings are discussed in relation to the Hemoccult II (H-O) test results obtained in these subjects, and the implications for the possible future role for this test in screening for colorectal neoplasia.

Entities:  

Mesh:

Year:  1982        PMID: 6819850     DOI: 10.1111/j.1445-2197.1982.tb06128.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  13 in total

Review 1.  Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Authors:  Alan S Rosman; Mark A Korsten
Journal:  J Gen Intern Med       Date:  2010-05-25       Impact factor: 5.128

Review 2.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

3.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

Review 4.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 6.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

7.  A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.

Authors:  N Armitage; J D Hardcastle; S S Amar; T W Balfour; J Haynes; P D James
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

8.  Immunological detection of occult blood in bowel cancer patients.

Authors:  A Kapparis; D Frommer
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

9.  Immunological detection of faecal occult blood in colorectal cancer.

Authors:  M J Turunen; K Liewendahl; P Partanen; H Adlercreutz
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

10.  Screening for colorectal cancer in a factory-based population with Fecatest.

Authors:  F I Lee
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.